Head of Investor Relations
Teva Pharmaceutical Industries Ltd (TEVA)Equibles does not estimate personal net worth.
Get an email with a short summary when Teva Pharmaceutical Industries Ltd publishes a filing, an earnings call transcript or a press release.
Get TEVA alertsRan Meir is recorded as Head of Investor Relations at Teva Pharmaceutical Industries Ltd (TEVA). Ran Meir has spoken on 3 earnings calls across 1 company, most recently for Teva Pharmaceutical Industries Ltd on November 6, 2024. Teva Pharmaceutical Industries Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Teva Pharmaceutical Industries Ltd includes Richard Francis (CEO and Board Member), Eli Kalif (CFO), Amir Weiss (Chief Accounting Officer) and 7 others.
“We hope you have had a chance to review our Q3 results press release, which was issued earlier this morning. A copy of the press release, along with the Slides presented during this call, are available on our website at ir.Tevapharm.com. Please review our forward-looking statements on Slide 2.”
“We hope you have had a chance to review our Q2 results press release, which was issued earlier this morning. A copy of the press release, along with the slides presented during this call, are available on our website at ir.Tevapharm.com. Please review our forward-looking statements on Slide 2.”
“We hope you have had a chance to review our Q1 results press release, along with the press release announcing positive Phase III results from the olanzapine LAI trial, both issued earlier this morning.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
